TY - JOUR
T1 - Unveiling the roots of monogenic genodermatoses
T2 - Genotrichoses as a paradigm
AU - Betz, Regina C.
AU - Cabral, Rita M.
AU - Christiano, Angela M.
AU - Sprecher, Eli
N1 - Funding Information:
Regina C. Betz is recipient of a Heisenberg Professorship from the German Research Foundation (DFG).
PY - 2012/3
Y1 - 2012/3
N2 - The past two decades have seen significant and unprecedented progress in human genetics owing to the advent of novel molecular biological technologies and major developments in computational methods. Dermatology has benefited from and, in some cases, led these advances. In this article, we review major discoveries in the field of inherited hair diseases, which illustrate the changes that genodermatology has undergone in recent years from a mostly descriptive discipline through the elucidation of the molecular basis of numerous disorders, up to the first attempts at translating these new findings into novel preventive and therapeutic tools to the benefit of our patients.
AB - The past two decades have seen significant and unprecedented progress in human genetics owing to the advent of novel molecular biological technologies and major developments in computational methods. Dermatology has benefited from and, in some cases, led these advances. In this article, we review major discoveries in the field of inherited hair diseases, which illustrate the changes that genodermatology has undergone in recent years from a mostly descriptive discipline through the elucidation of the molecular basis of numerous disorders, up to the first attempts at translating these new findings into novel preventive and therapeutic tools to the benefit of our patients.
UR - https://www.scopus.com/pages/publications/84856814861
U2 - 10.1038/jid.2011.408
DO - 10.1038/jid.2011.408
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
AN - SCOPUS:84856814861
SN - 0022-202X
VL - 132
SP - 906
EP - 914
JO - Journal of Investigative Dermatology
JF - Journal of Investigative Dermatology
IS - 3 PART 2
ER -